» Articles » PMID: 31165058

Understanding the Nano-bio Interfaces: Lipid-Coatings for Inorganic Nanoparticles As Promising Strategy for Biomedical Applications

Overview
Journal Front Chem
Specialty Chemistry
Date 2019 Jun 6
PMID 31165058
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Inorganic nanoparticles (NPs) exhibit relevant physical properties for application in biomedicine and specifically for both the diagnosis and therapy (i.e. theranostic) of severe pathologies, such as cancer. The inorganic NP core is often not stable in aqueous suspension and can induce cytotoxic effects. For this reason, over the years, several coating strategies were suggested to improve the NP stability in aqueous solutions as well as the NP biocompatibility. Among the various components which can be used for NP coatings, lipids, and in particular phospholipids emerged as versatile molecular building blocks for the production of NP coatings suitable for biomedical application. The recent synthetic efforts in NP lipid coatings allows today to introduce on the NP surface a large variety of lipid molecules eventually in mixture with amphiphilic or hydrophobic drugs or active molecules for cell targeting. In this review, the most relevant examples of NP lipid-coatings are presented and grouped in two main categories: supported lipid bilayers (SLB) and hybrid lipid bilayers (HLB). The discussed scientific cases take into account the most commonly used inorganic NP for biomedical applications in cancer therapy and diagnosis.

Citing Articles

Microfluidics-Driven Manufacturing and Multiscale Analytical Characterization of Nanoparticle-Vesicle Hybrids.

Cardellini J, Normak K, Gerlt M, Makasewicz K, Seiffert C, Capasso Palmiero U Adv Healthc Mater. 2024; 14(4):e2403264.

PMID: 39722148 PMC: 11804839. DOI: 10.1002/adhm.202403264.


Biomimetic Nanoparticles for Basic Drug Delivery.

Tikhonov A, Kachanov A, Yudaeva A, Danilik O, Ponomareva N, Karandashov I Pharmaceutics. 2024; 16(10).

PMID: 39458635 PMC: 11510494. DOI: 10.3390/pharmaceutics16101306.


Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines.

Havelikar U, Ghorpade K, Kumar A, Patel A, Singh M, Banjare N Discov Nano. 2024; 19(1):165.

PMID: 39365367 PMC: 11452581. DOI: 10.1186/s11671-024-04118-1.


Cellular uptake and viability switching in the properties of lipid coated carbon quantum dots for potential bioimaging and therapeutics.

Jain S, Sahu N, Bhatia D, Yadav P Nanoscale Adv. 2024; .

PMID: 39170765 PMC: 11333955. DOI: 10.1039/d4na00306c.


Medical Device-Associated Infections Caused by Biofilm-Forming Microbial Pathogens and Controlling Strategies.

Mishra A, Aggarwal A, Khan F Antibiotics (Basel). 2024; 13(7).

PMID: 39061305 PMC: 11274200. DOI: 10.3390/antibiotics13070623.


References
1.
Liu X, Situ A, Kang Y, Villabroza K, Liao Y, Chang C . Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer. ACS Nano. 2016; 10(2):2702-15. PMC: 4851343. DOI: 10.1021/acsnano.5b07781. View

2.
Mahyad B, Janfaza S, Hosseini E . Bio-nano hybrid materials based on bacteriorhodopsin: Potential applications and future strategies. Adv Colloid Interface Sci. 2015; 225:194-202. DOI: 10.1016/j.cis.2015.09.006. View

3.
Mirahadi M, Ghanbarzadeh S, Ghorbani M, Gholizadeh A, Hamishehkar H . A review on the role of lipid-based nanoparticles in medical diagnosis and imaging. Ther Deliv. 2018; 9(8):557-569. DOI: 10.4155/tde-2018-0020. View

4.
Papagiannaros A, Levchenko T, Hartner W, Mongayt D, Torchilin V . Quantum dots encapsulated in phospholipid micelles for imaging and quantification of tumors in the near-infrared region. Nanomedicine. 2009; 5(2):216-24. DOI: 10.1016/j.nano.2008.10.001. View

5.
Nel A, Madler L, Velegol D, Xia T, Hoek E, Somasundaran P . Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009; 8(7):543-57. DOI: 10.1038/nmat2442. View